ライフサイエンスコーパス: CSF culture

1 1 RNA detection (without any positive CFU in CSF culture).

2 of 16 by CMV antigen assay, and 11 of 15 by CSF culture.

3 (19.1%) had definite TBM based on a positive CSF culture.

4 g, as well as agreement between CSF CrAg and CSF culture.

5 F glucose compared with the gold standard of CSF culture.

6 nduction therapy and had serial quantitative CSF cultures.

7 onse despite antifungal therapy and negative CSF cultures.

8 culture-positive meningitis and two or more CSF cultures.

9 ility of routinely querying for anaerobes in CSF cultures.

10 ZBTB46 and prolonged STAT5 activation in GM-CSF cultures.

11 als infected with K1(-) strains had positive CSF cultures.

12 d F. tularensis grew in cerebrospinal fluid (CSF) culture.

13 al therapy and negative cerebrospinal fluid (CSF) cultures.

14 Three patients had positive CSF cultures after 30 days of treatment; reference tests

15 His CSF culture also was positive for H capsulatum.

16 amples were collected and processed for both CSF culture and 16S ONT sequencing.

17 CSF cultures and cytology are infrequently positive.

18 months tended to be lower in patients whose CSF cultures at 2 weeks were positive compared to those

19 tion from pulmonary CD11c+ cells and from GM-CSF-cultured bone marrow cells (BMCs(GM-CSF)).

20 DCs and macrophages in GM-CSF cultures both undergo maturation upon stimulation wi

21 had lower quantitative cerebrospinal fluid (CSF) culture burden (median [IQR], 4570 [11-100 000] vs

22 CSF cultures did not show any evidence of growth of bact

23 CSF culture, DNA tests for cytomegalovirus and Epstein-B

24 in testing by blood and cerebrospinal fluid (CSF) culture during the pandemic.

25 f CD69 MoAb P8, also induced apoptosis in GM-CSF cultured eosinophils.

26 tities of TGF beta 1 in supernatants from GM-CSF--cultured eosinophils ligated with CD69 or control M

27 ion could not be excluded without a repeated CSF culture, even in the absence of pleocytosis.

28 d persistently positive cerebrospinal fluid (CSF) cultures for 13 days despite treatment with high-do

29 In contrast, DCs derived from GM-CSF cultures had low levels of MHC class II costimulatio

30 detected pathogens in 28 samples (9%), while CSF culture identified pathogens in 23 samples (7%).

31 cing identified 17 pathogens not detected by CSF culture, including Streptococcus suis and Acinetobac

32 We compared initial cerebrospinal fluid (CSF) cultures, inflammatory markers, and cytokine profil

33 lation with active HCMV CNS disease, whereas CSF culture is insensitive and qualitative DNA PCR may d

34 ed bacterial meningitis were included if the CSF culture isolate was consistent with meningitis or if

35 ls via Fc alpha RI than Fc gamma RI, while M-CSF-cultured MDM were relatively less efficient in media

36 gy (ONT) sequencing compared to conventional CSF culture methods, with the goal of improving diagnost

37 , rifampicin resistance in positive blood or CSF cultures, mortality, clinical outcomes at neonatal u

38 CrAg, 9% (5/54) had Cryptococcus isolated on CSF culture (n = 3) or PCR (n = 2) and 11% (6/54) had co

39 in the positivity of a cerebrospinal fluid (CSF) culture or CSF antibody, particularly if the primar

40 CSF CrAgSQ grades 3+ or higher were always CSF culture positive.

41 with ABM (n = 523 [65%] cerebrospinal fluid [CSF] culture positive).

42 1.16 per 0.10 decrease; 95% CI, 1.04-1.30), CSF culture positivity (HR, 1.37; 95% CI, 1.02-1.84), an

43 was 8.9% (95% CI 5.0-15.4), and frequency of CSF culture positivity for Mycobacterium tuberculosis wa

44 were strongly associated with poor outcome (CSF culture positivity, CSF white blood cell count, hemo

45 higher sensitivity and diagnostic yield than CSF culture, providing clinical insights for managing CN

46 fter the completion of antibiotic treatment, CSF cultures remained negative, but PCR/ESI-MS again fou

47 CSF cultures remained negative.

48 ctam-durlobactam and meropenem; 4 subsequent CSF cultures remained negative.

49 atients with polyradiculopathy and follow-up CSF culture showed a drop in CMV DNA after treatment; ho

50 To that end, we assessed CSF cultures submitted over a 2-year period.

51 Blood and CSF culture testing rates during the pandemic were compa

52 Agreement between CSF CrAg and CSF culture was 98% (97-99).

53 Among cases with available data, CSF culture was positive in 13 of 16 cases, and F. tular

54 weeks were positive compared to those whose CSF cultures were negative (50% vs. 91%, P = 0.06).

55 e antimicrobial treatment was initiated, all CSF cultures were negative.

56 linical improvement and results of follow-up CSF cultures were negative.

57 Both CSF cultures were negative.

58 Patients with TBM-non-IRIS whose CSF cultures were positive for M. tuberculosis at TBM di